stockrow
Friday 6 November 2026
Export IMCC’s income statement to Excel — free account
IM Cannabis Corp.
IMCC Healthcare Drug Manufacturers Specialty & Generic
IM Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $39.2 million, down 0.66% from fiscal 2024.
- Revenue
- −40.3%
- EPS
- −385.7%
- Free cash flow
- −266.8%
- Total debt
- −64.7%
Quarter to June 2026, against a year earlier
0.59
0.00
0.00%
Follow IMCC
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 2 | 3 | 2 | 1 | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
P/S ratio |
0.15 | 0.14 | 0.12 | 0.19 | 4.47 | 25.27 | 0.00 | — | — | — |
Altman Z-Score |
(11.69) | (8.96) | (7.12) | (6.18) | 1.41 | 8.62 | 92.07 | — | — | — |
P/FCF ratio |
1.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Altman Z″-Score (non-manufacturers) |
(32.65) | (25.14) | (19.14) | (15.73) | 1.89 | (0.16) | 4.07 | — | — | — |
Beneish M-Score |
(5.42) | (3.59) | (2.65) | (4.63) | 2.63 | (4.30) | — | — | — | — |
P/Operating CF |
1.95 | (1.78) | (34.54) | (3.96) | 52.86 | (50.83) | (10.34) | — | — | — |
P/B ratio |
0.00 | 2.38 | 0.43 | 0.43 | 1.18 | 31.92 | 0.79 | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 1.66 | 4.60 | 35.90 | 0.83 | — | — | — |
EV/Sales |
0.12 | 0.17 | 0.31 | 0.33 | 4.69 | 24.77 | 0.00 | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.77 | 0.00 | — | — | — |
EV/Operating CF |
1.37 | (8.36) | (1.87) | (1.41) | (7.41) | (26.12) | 0.00 | — | — | — |
EV/FCF |
1.36 | (7.92) | (1.75) | (1.27) | (6.54) | (26.12) | 0.00 | — | — | — |
Quick Ratio |
0.42 | 0.42 | 0.41 | 0.43 | 0.94 | 2.41 | 6.13 | 0.02 | 0.00 | 0.00 |
Current Ratio |
0.67 | 0.67 | 0.74 | 0.97 | 1.65 | 4.33 | 9.31 | 0.02 | 0.00 | 0.00 |
Net Debt/EBITDA |
0.18 | (0.18) | 0.14 | (0.30) | (0.35) | 1.05 | 1.07 | 0.03 | (0.31) | (0.11) |
Debt/Assets |
4.91% | 6.21% | 0.81% | 16.62% | 10.13% | 2.62% | 3.40% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(0.43) | 0.77 | 0.03 | 0.42 | 0.14 | 0.08 | 0.04 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.53 | 1.22 | 0.87 | 0.30 | 0.34 | 0.45 | 0.59 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
(0.42) | 0.10 | 0.85 | 0.07 | 1.94 | 0.28 | 0.82 | 0.77 | 0.00 | 0.58 |
Capex/Depreciation |
(0.01) | (0.03) | (0.24) | (0.25) | (1.10) | (3.76) | 0.00 | — | — | 0.00 |
Interest Coverage |
(3.31) | (2.29) | (3.48) | (15.61) | (23.29) | (0.40) | (35.74) | (2,498.00) | (61.20) | (178.00) |
| 5,561.96% | (124.14%) | (49.46%) | (159.81%) | (16.39%) | (150.96%) | (41.07%) | (1.05%) | (0.14%) | (0.39%) | |
| (31.57%) | (23.86%) | (16.99%) | (105.29%) | (11.00%) | (82.05%) | (47.19%) | (2,658.95%) | (11,376.00%) | (14,615.39%) | |
ROIC |
0.00% | (137.46%) | (65.10%) | (61.22%) | (11.05%) | (109.50%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
149.84% | 135.29% | 272.54% | (4,636.51%) | (28.04%) | (108.68%) | (27.94%) | 27.36% | 3.66% | 10.96% |
Average Days of Receivables |
72.34 | 93.24 | 86.31 | 80.66 | 209.67 | 142.19 | 82.86 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.86% | 2.57% | — | — | — |
Selling, General and Administrative Expense of Revenue |
27.20% | 28.61% | 45.12% | 65.46% | 89.66% | 116.91% | 113.94% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.10 | 0.26 | 0.33 | 0.29 | 0.53 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.03% | 2.09% | 0.46% | 6.93% | 15.24% | 21.28% | 0.00% | — | — | — |
Graham Net Nets |
(1.53) | (1.69) | (1.84) | (0.42) | 0.01 | 0.00 | 0.99 | — | — | — |
Graham Number |
155.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Earnings Yield |
(140.68%) | (112.23%) | (156.21%) | (1,871.88%) | (5.69%) | (5.38%) | (5.38%) | — | — | — |
Free Cash Flow Yield |
57.99% | (15.17%) | (147.11%) | (138.10%) | (16.05%) | (3.75%) | 0.00% | — | — | — |
Revenue per Share |
277.42 | 504.24 | 507.78 | 1,047.48 | 1,345.53 | 554.29 | 2.18 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
23.90 | (10.05) | (84.02) | (243.68) | (851.72) | (276.24) | (1.43) | (0.26) | 0.00 | (0.01) |
Capex per Share |
(0.07) | (0.56) | (6.04) | (26.07) | (113.86) | (94.53) | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
23.84 | (10.61) | (90.06) | (269.74) | (965.58) | (370.77) | (1.43) | (0.26) | 0.00 | (0.01) |
Cash per Share |
16.77 | 8.65 | 18.86 | 47.21 | 422.07 | 310.57 | 3.35 | 0.01 | 0.00 | 0.00 |
Shareholders Equity per Share |
(18.32) | 29.36 | 142.54 | 458.76 | 5,078.43 | 439.88 | 5.93 | 0.00 | 35.24 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(18.32) | 29.36 | 142.54 | 458.76 | 5,078.43 | 439.88 | 5.93 | 0.00 | 35.24 | 0.00 |
Free Cash Flow |
3.37 | (0.83) | (6.41) | (10.76) | (31.09) | (7.93) | (4.58) | (0.07) | — | (0.02) |
Working Capital |
(8.06) | (8.43) | (6.33) | (0.88) | 26.40 | 15.58 | 16.68 | (0.34) | (0.35) | (0.31) |
Capital Expenditures |
(0.01) | (0.04) | (0.43) | (1.04) | (3.67) | (2.02) | (1.19) | — | — | — |
Net Current Asset Value |
(9.02) | (9.25) | (8.04) | (3.24) | 1.49 | 1.22 | 15.00 | 0.01 | (0.35) | 0.00 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.77 | 0.00 | — | — | — |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.02 | 0.08 | 0.17 | 0.00 | — | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 25.27 | 0.00 | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.44 | 0.49 | 0.47 | 1.03 | 0.14 | 0.13 | 0.14 | — | — | 0.00 |
Cash ROIC |
375.62% | (17.47%) | (54.42%) | (38.51%) | (15.52%) | (47.21%) | (15.03%) | (2,402.50%) | 0.00% | (511.54%) |
Accounts Receivable Turnover |
4.39 | 4.23 | 4.07 | 2.45 | 2.94 | 3.82 | 8.79 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
3.84 | 4.44 | 3.10 | 2.89 | 5.16 | 3.90 | 6.09 | — | — | 0.00 |
Inventory Turnover |
11.94 | 6.83 | 2.86 | 1.76 | 2.18 | 0.85 | 1.09 | — | — | 0.00 |
Average Days of Payables |
97.68 | 89.36 | 86.41 | 129.84 | 120.37 | 134.28 | 32.52 | — | — | 0.00 |
Days of Inventory on Hand |
34.58 | 25.75 | 93.47 | 140.64 | 267.42 | 435.46 | 263.51 | — | — | 0.00 |
Average Receivables |
8.92 | 9.31 | 8.89 | 17.06 | 14.75 | 3.10 | 0.79 | 0.00 | 0.00 | 0.00 |
Average Payables |
8.39 | 7.49 | 9.31 | 11.47 | 6.55 | 1.35 | 1.41 | — | — | — |
Average Inventory |
2.70 | 4.87 | 10.07 | 18.78 | 15.55 | 6.25 | 7.84 | — | — | — |
Average Assets |
25.66 | 32.38 | 41.42 | 137.99 | 128.88 | 26.11 | 11.89 | 0.00 | 0.00 | 0.00 |
Average Common Equity |
(0.15) | 6.22 | 14.23 | 90.92 | 86.47 | 14.19 | 13.66 | 8.72 | 8.77 | 8.77 |
Columns are period end dates · fundamentals updated 2 Nov 2026